Hippocratic AI has successfully concluded its Series B funding round, securing $141 million, which values the company at an impressive $1.64 billion. The firm specializes in developing AI agents designed to manage non-diagnostic medical tasks, including preoperative preparations and remote patient monitoring. With existing contracts already in place with 23 healthcare systems and insurance providers, this infusion of capital will propel Hippocratic AI into new markets and further solidify its position in the industry.